<DOC>
	<DOCNO>NCT02985541</DOCNO>
	<brief_summary>The study perform assess Mirena effective safe birth control method beyond 5 year use . Further menstrual blood loss ( woman Mirena insert indication heavy menstrual bleeding [ HMB ] ) safety assess .</brief_summary>
	<brief_title>Mirena Extension Trial</brief_title>
	<detailed_description />
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Signed date informed consent Women , 18 35 year age time screen ( visit 1 ) currently use Mirena contraception contraception heavy menstrual bleeding . The duration use current Mirena least 4 year 6 month start screen phase 5 year visit 2 woman willing continue use continue need contraception . Normal clinically insignificant cervical smear require follow Menopausal symptom Folliclestimulating hormone &gt; 30 mIU/ml Pregnancy suspicion pregnancy Uterine bleed unknown etiology Untreated acute cervicitis vaginitis low genital tract infection Increased susceptibility pelvic infection Acute pelvic inflammatory disease ( PID ) history PID unless successfully treat , investigator 's opinion , negatively affect subject 's fertility Congenital acquire uterine anomaly distorts uterine cavity History , diagnose suspect genital malignancy untreated cervical dysplasia Any active acute liver disease liver tumor ( benign malignant ) Clinically significant endometrial polyp ( )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Birth Control</keyword>
	<keyword>Heavy menstrual bleeding</keyword>
</DOC>